Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-111396
Filing Date
2025-11-13
Accepted
2025-11-13 16:34:49
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mxct-20250930x10q.htm   iXBRL 10-Q 1896686
2 EX-31.1 mxct-20250930xex31d1.htm EX-31.1 15559
3 EX-31.2 mxct-20250930xex31d2.htm EX-31.2 14807
4 EX-32.1 mxct-20250930xex32d1.htm EX-32.1 7624
5 EX-32.2 mxct-20250930xex32d2.htm EX-32.2 7017
  Complete submission text file 0001104659-25-111396.txt   8330591

Data Files

Seq Description Document Type Size
6 EX-101.SCH mxct-20250930.xsd EX-101.SCH 45110
7 EX-101.CAL mxct-20250930_cal.xml EX-101.CAL 62786
8 EX-101.DEF mxct-20250930_def.xml EX-101.DEF 210674
9 EX-101.LAB mxct-20250930_lab.xml EX-101.LAB 452329
10 EX-101.PRE mxct-20250930_pre.xml EX-101.PRE 346099
77 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20250930x10q_htm.xml XML 1520592
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40674 | Film No.: 251479176
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)